Mostrar el registro sencillo del ítem

dc.contributor.authorRyan, Pablo
dc.contributor.authorValencia, Jorge
dc.contributor.authorCuevas, Guillermo
dc.contributor.authorTroya, Jesús
dc.contributor.authorTorres-Macho, Juan
dc.contributor.authorMuñoz-Gómez, María José 
dc.contributor.authorMuñoz-Rivas, Nuria
dc.contributor.authorCanorea, Isabel 
dc.contributor.authorVazquez-Moron, Sonia 
dc.contributor.authorResino, Salvador 
dc.date.accessioned2022-04-28T10:19:24Z
dc.date.available2022-04-28T10:19:24Z
dc.date.issued2021-08-19
dc.identifier.citationInfect Dis Poverty. 2021;10(1):111.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/14213
dc.description.abstractBackground: The burden of human immunodeficiency virus (HIV) infection in people who use drugs (PWUD) is significant. We aimed to screen HIV infection among PWUD and describe their retention in HIV care. Besides, we also screen for hepatitis C virus (HCV) infection among HIV-seropositive PWUD and describe their linkage to care. Methods: We conducted a prospective study in 529 PWUD who visited the "Cañada Real Galiana" (Madrid, Spain). The study period was from June 1, 2017, to May 31, 2018. HIV diagnosis was performed with a rapid antibody screening test at the point-of-care (POC) and HCV diagnosis with immunoassay and PCR tests on dried blood spot (DBS) in a central laboratory. Positive PWUD were referred to the hospital. We used the Chi-square or Fisher's exact tests, as appropriate, to compare rates between groups. Results: Thirty-five (6.6%) participants were positive HIV antibodies, but 34 reported previous HIV diagnoses, and 27 (76%) had prior antiretroviral therapy. Among patients with a positive HIV antibody test, we also found a higher prevalence of homeless (P < 0.001) and injection drug use (PWID) (P < 0.001), and more decades of drug use (P = 0.002). All participants received HIV test results at the POC. Of the 35 HIV positives, 28 (80%) were retained in HIV medical care at the end of the HIV screening study (2018), and only 22 (62.9%) at the end of 2020. Moreover, 12/35 (34.3%) were positive for the HCV RNA test. Of the latter, 10/12 (83.3%) were contacted to deliver the HCV results test (delivery time of 19 days), 5/12 (41.7%) had an appointment and were attended at the hospital and started HCV therapy, and only 4/12 (33.3%) cleared HCV. Conclusions: We found almost no new HIV-infected PWUD, but their cascade of HIV care was low and remains a challenge in this population at risk. The high frequency of active hepatitis C in HIV-infected PWUD reflects the need for HCV screening and reinforcing the link to care.es_ES
dc.description.sponsorshipThis work was funded by a research grant from Merck Sharpe & Dohme (Grant Number MISP IIS#54846) and Instituto de Salud Carlos III (ISCII; Grant Numbers PI20CIII/00004, and RD16CIII/0002/0002 to SR). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.es_ES
dc.language.isoenges_ES
dc.publisherBioMed Central (BMC) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAntiviral treatmentes_ES
dc.subjectDried blood spotes_ES
dc.subjectHIVes_ES
dc.subjectHepatitis Ces_ES
dc.subjectPeople who use drugses_ES
dc.subjectPoint-of-carees_ES
dc.subjectRetention in carees_ES
dc.subjectScreeninges_ES
dc.titleHIV screening and retention in care in people who use drugs in Madrid, Spain: a prospective studyes_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID34412695es_ES
dc.format.volume10es_ES
dc.format.number1es_ES
dc.format.page111es_ES
dc.identifier.doi10.1186/s40249-021-00894-5es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.contributor.funderMerck, Sharp & Dohme es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn2049-9957es_ES
dc.relation.publisherversionhttps://doi.org/10.1186/s40249-021-00894-5es_ES
dc.identifier.journalInfectious Diseases of Povertyes_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI20CIII/00004es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/RD16CIII/0002/0002es_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional